Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis

QJM: An International Journal of Medicine

Volumn 91, Issue 6, 1998, Pages 401-409

  Bhandari, S ^a   Harnden, P ^a   Brownjohn, A M ^a   Turney, J H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GLOMERULUS CAPILLARY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0031834325     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.6.401     Document Type: Article

References (46)

1. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Haemost Thromb 1972; 1:75-95.
2. Bevers EM, Galli M, Barbui T, et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66:629-32.
3. Galli M. Anticardiolipin antibody (ACA) directed not to cardiolipin but to plasma protein cofactor. Lancet 1990; 335:1544-7.
4. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4.
5. Meroni PL, Del Papa N, Gambini D, Tincami A, Balesterari G. Antiphospholipid antibodies and endothelial cells: an unending story. Lupus 1995; 4:169-71.
6. Alarcon-Segovia D, Cabrai AR. The antiphospholipid/ cofactors syndromes. J Rheumatol 1996; 23:1319-22.
7. Alarcon-Segovia, Cabrai AR. The concept and classification of antiphospholipid/cofactor syndromes. Lupus 1996; 5:364-7.
8. Hughes GRV, Asherson RA, Khamashta MA. Antiphospholipid syndrome: Linking many specialities. Ann Rheum Dis 1989; 48:355-6.
9. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GR. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosis, lupus-like disease and the primary antiphospholipid syndrome. Am J Med 1989; 86:391-9.
10. Hughes GR, Harris NM, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13:486-9.
11. Mackworth-Young CG, Loizou S, Walportt MJ. Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorders. Ann Rheum Dis 1989; 48:362-7.
12. Kant KS, Pollak VE, Weiss MA, Gleuck HI, Miller MA, Hess EV. Glomerular thrombosis in SLE: Prevalence and significance. Medicine 1988; 60:71-85.
13. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M, Thrombosis in SLE: relationship with the presence of circulating anticoagulants. Arch Intern Med 1985; 145:1389-95.
14. Frampton G, Hicks J, Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991; 39:1225-31.
15. Miranda JM, Garcia-Torres R, Jara LJ, Medina F, Cervera H, Fraga A. Renal biopsy in SLE: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 1994; 3:25-9.
16. Leaker B, Fairley KF, Dowling J, Kincaid-Smith P. Lupus nephritis: Q J Med 1987; 62:163-79.
17. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: Report of an International Workshop held on 4th April 1986. Clin Exp Immunol 1987; 68:215-22.
18. Conley CL, Hartmann RC. A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosis. J Clin Invest 1952; 31:621-2.
19. Kandish DA, Krilis SA, Immunology and methods of detection of antiphospholipid antibodies. In: Asherson RA, Cevera R, Piette J-C, Shoenfeld Y, eds. The Antiphospholipid syndrome. Boca Raton, CRC Press, 1996:29-48.
20. Levine SR, Welch KMA. The spectrum of neurological disease: Association with antiphospholipid antibodies. Arch Neurol 1987; 44:876-83.
21. Kelly RE, Gillman PB, Kovacs AG. Cerebral ischaemia in the presence of lupus anticoagulant. Arch Neurol 1984; 41:521-3.
22. Gastineau DA, Kaziemier FG, Nochols WA, Bowie W. Lupus anticoagulant: analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19:265-75.
23. Ford PH, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in SLE. J Rheumatol 1988; 15:507-600.
24. Asherson RA, Mayou SC, Merry P, Black MM, Hughes GR. The spectrum of livido reticularis and anticardiolipin antibodies and CNS disease. Br J Dermatol 1989; 120:215-21.
25. Hamsten A, Bjorkholm M, Norbers R, de Faire U, Holm G. Antibodies to cardiolipin in infarction: An association with recurrent young survivors of myocardial cardiovascular events. Lancet 1986; 1:113-15.
26. Pomerory C, Knodell RG, Swain WR, Arneson P, Mahowald ML. Budd-Chiari syndrome in patients with lupus anticoagulant. Gastroenterology 1984; 86:158-61.
27. Bowie EJW, Thompson SH, Cascuzzi PA. Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 1963; 62:416.
28. Farrugia E, Torres VE, Gastineau D, Michel CJ, Holley KE. Lupus anticoagulant in SLE: A clinical and renal pathological Study. Am J Kid Dis 1992; 20:463-71.
29. Love PE, Santoro SA. Antiphospholipid antibodies. Anticardiolipin and the lupus anticoagulant in SLE and in non SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112:682-98.
30. D'Agati V, Kunis C, Williams G, Appel GB. Anti-cardiolipin antibodies and renal disease: A report of three cases. J Am Soc Nephrol 1990; 1:777-84.
31. Scolari F, Savoldi S, Costantino E, Spitti C, Franceschini F, Tardanico R, Morassi I, Maiorca R. Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis. Nephrol Dial Transplant 1993; 6:1274-6.
32. Viard JP, Amoura Z, Bach JF. Association of anti-beta-2-glycoprotein antibodies with lupus-type circulating anticoagulants and thrombosis in systemic lupus erythematosis. Am J Med 1992; 93:181-6.
33. Martinuzzo ME, Forastiero RR, Carreras LO. Anti-beta-2 gylcoprotein antibodies: detection and association with thrombosis. Br J Haematol 1995; 89:397-402.
34. E. McNally T, Mackie IJ, Machin SJ, Isenberg DA, Increased levels of b2-glycoprotein-1 antigen and b2-glycoprotein-1 binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995; 34:1031-6.
35. 2-glycoprotein-I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. Ann Med Intern 1996; 147(Suppl I):42-3.
36. Sorice M, Circella A, Griggi T, Gardfalot T, Nicodemo G, Pittoni V, Potieri G, Lenti L, Valesini G. Anticardiolipin and anti-b2-GPI are two distinct populations of autoantibodies. Thromb Haemostasis 1996; 75:303-8.
37. Watson KV, Schorer AE. Lupus anticoagulant inhibition of the in vitro prostacyclin release is associated with a thrombosis prone subset of patients. Am J Med 1991; 90:47-53.
38. Cariou R, Tobelem G, Soria C, Caen J. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med 1986; 314:1193-4.
39. Hasselaar P, Derksen RH, Bjokzijl L, de Groot PG. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects of endothelial and platelet prostanoid synthesis. Thromb Haemost 1988; 59:80-5.
40. De Prost D, Ollivier V, Ternisien C, Chollet-Martin S. Increased monocyte procoagulant in patients with systemic lupus erythematosis. Thromb Haemost 1990; 64:216-21.
41. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988; 85:602-8.
42. Kincaid-Smith PK, Nicholls K. Renal thrombotic microvascular disease associated with lupus anticoagulant. Nephron 1990; 1:777-84.
43. Appel GB, Silva FG, Pirani CL, Meltzer Estes D. Renal involvement in SLE: A study of 56 patients emphasising histological classification. Medicine 1993; 57:5, 371-410.
44. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis clinical course as related to morphologic forms and their transitions. Am J Medicine 1977; 62:12-30.
45. Esdaile JM, Levinton C, Federgreen, Hayslett JP, Kashgarian. The clinical and renal biopsy predictors of long term outcome in lupus nephritis: A study of 87 patients and review of the literature. Q J Med 1989; 72:269, 779-833.
46. Austin HA, Boumpas DT, Vaughan EM, Balow JE. High risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10:1620-8.